Transgenomic, Inc. (Nasdaq: TBIO), and privately-held Precipio Diagnostics, LLC, announced entry into a merger agreement, pursuant to which ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE